A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery
Clinical trial NCT00361582 · COMPLETED
Trial details
- NCT number
- NCT00361582
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-08-01
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.